期刊： NATURE MEDICINE, 2021; 27 (4)
Bronchiectasis, a progressive chronic airway disease, is characterized by microbial colonization and infection. We present an approach to the multi-bi......
期刊： NATURE MEDICINE, 2021; 27 (7)
Pay-it-forward programs, whereby someone receives a gift or free service and then gives a gift to another person in return, have expanded during the C......
期刊： NATURE MEDICINE, 2021; 27 (6)
An effective vaccine is needed to end the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Here, we assess the preliminary safet......
期刊： NATURE MEDICINE, 2021; 27 (3)
Angiotensin-converting enzyme 2 (ACE2) and accessory proteases (TMPRSS2 and CTSL) are needed for severe acute respiratory syndrome coronavirus 2 (SARS......
期刊： NATURE MEDICINE, 2021; 27 (7)
Fecal microbial transplantation (FMT) from lean donors to patients with obesity has been associated with metabolic benefits, yet results so far have b......
期刊： NATURE MEDICINE, 2021; 27 (5)
Transcriptomic and proteomic profiling of breast cancer biopsies identifies baseline features of the tumor immune microenvironment associated with T c......
期刊： NATURE MEDICINE, 2021; 27 (8)
The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among c......
We engineered three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses containing key spike mutations from the newly emerged United ......
B cell maturation antigen (BCMA) is a target for various immunotherapies and a biomarker for tumor load in multiple myeloma (MM). We report a case of ......
A comprehensive analysis of antibody neutralization activity against a panel of authentic isolates and chimeric SARS-CoV-2 variants shows markedly dim......
期刊： NATURE MEDICINE, 2021; 27 (3)
Animal studies implicate meningeal lymphatic dysfunction in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease and Parkinson's......
期刊： NATURE MEDICINE, 2021; 27 (3)
Despite advances in technologies for cardiac repair after myocardial infarction (MI), new integrated therapeutic approaches still need to be developed......
